Dr. Chaitanyanand B. Koppiker, M.D. a Breast Oncoplastic Surgeon and the Medical Director of Orchids Breast Health Center, Pune, India. His was trained at B.J. Medical College, Pune and at the Tata Memorial Hospital, Mumbai. Thereafter he completed a Surgical Fellowship in Breast Oncoplastic Surgery (OBS) at the (Klinik für Senologie und Brustchirurgie Brustzentrum am Marien Hospital Düsseldorf Germany and St George Hospital Sydney, (Australia ) and has been trained in several international workshops in OBS.
Dr Koppiker established the 1st integrated cancer center in Pune ( Budhrani Cancer Institute at the Inlaks and Budhrani Hospital, Pune). He then served as the Director of the Ruby Hall Clinic Cancer Center and the Cancer Clinic and Research Center at Jehangir Hospital in Pune. He has then established a center of excellence for breast Health a unique facility with integrated solutions for breast care – ORCHIDS BREAST HEALTH.
He has attended as Faculty and Trainer in Oncoplastic surgery several National and international workshops. He has been an invited faculty at the Ameriacn Society Of Breast Diseases wprkshop on Oncoplastic Surgery , East Anglia University’s Mastership Program and several National workshops and conferences.
Dr. Koppiker’s current professional interests include:
Dr Tanweer Shahid is a Senior Consultant Radiation Oncologist working at Apollo Gleneagles Hospital Kolkata.
He has done his post-graduation in 2007 and his Senior Residency from Tata Memorial Hospital, Mumbai.
His main interest is Breast and Head and Neck Cancer. He also has significant work in paediatrics brain tumours.
His major publication is in head and neck cancer.
He has received many fellowships and grants.
At present his major ongoing work is in radiotherapy of breast by hypofractionation schedules.
Nagi S. El-Saghir, MD, FACP is Professor of Clinical Medicine and Director of Breast Center of Excellence, Division of Hematology Oncology, Department of Internal Medicine, Naef K. Basile Cancer Institute, American University of Beirut Medical Center.
Dr. El Saghir graduated from Universite Libre de Bruxelles, completed his training in Internal Medicine at The Brooklyn Hospital-State University of New York, Hematology Oncology at St. Luke’s Roosevelt Hospital Center-Columbia University College of Physicians & Surgeons in New York, and is certified by the American Boards of Internal Medicine and Medical Oncology. He joined the clinical faculty as Clinical Instructor at State University of New York SUNY-Downstate at Long Island College Hospital and Brooklyn Hospital in New York. He worked as Acting Head of Hematology Oncology at King Khalid University Hospital, before returning to the USA where he practiced at Oakwood Hospital and was Clinical Assistant Professor at Wayne State University. Since he returned to Lebanon and joined AUBMC in 1993, Dr. El Saghir has built a very busy clinical practice along with a very productive career in teaching and research, as well professional and community services in Lebanon, Arab Countries and worldwide.
He is Director of the Breast Center of Excellence and leads the Multidisciplinary Breast Tumor Boards at AUBMC, Founding President of the Lebanese Society of Medical Oncology (LSMO), Past-President of the Lebanese Society of Internal Medicine, Past-Chair of International Affairs Committee of the American Society of Clinical Oncology (ASCO), Co-Chair of ASCO Guidelines Advisory Group for ASCO Clinical Practice Guidelines Committee, member of European Society of Medical Oncology ESMO Emerging Countries Committee, past National and Regional Representative ESMO, ESMO Developing Countries Task Force, ESMO/ASCO Global Curriculum Committee, ASCO Global Oncology Task Force, Official Nominee for ASCO Board of Directors, Co-Chair and Panel Member Breast Health Global Initiative (BHGI), Member of the Board of the Arab Association Against Cancer, and President of the Lebanese Breast Cancer Foundation.
Dr. El Saghir has over 100 publications in peer-reviewed journals and textbooks. His research is focused on breast cancer and young women, genetic mutations, awareness, early detection and screening, locally advanced and metastatic breast cancer, multidisciplinary management, treatment guidelines, multidisciplinary management and international phase III clinical trials. He published pioneering articles on epidemiology of cancer in Lebanon and Arab countries, locally advanced breast cancer, breast cancer in developing countries, BRCA mutations and resource-stratification guidelines. He is a Panel member and Co-author of ABC1, ABC2 and ABC3 International Consensus Guidelines for Advanced Breast Cancer published in The Breast and Annals of Oncology, Co-author of Resource-stratified Guidelines for Breast Cancer management (BHGI) published in Cancer, Breast Journal, The Breast, and Lancet Oncology. He is a regular speaker at Lebanese, Arab and international conferences including ASCO, ESMO, EBCC, ABC, BHGI and San Antonio as well as Pan Arab Cancer Congresses and Beirut Breast Cancer Conferences BBCC. He serves as regular peer reviewer, Deputy Editor for The Breast (2006-2013), Editorial Board Member of The Breast, ASCO’s Journal of Global Oncology JGO, ASCO Post and International Editor of Journal of Clinical Oncology JCO. He is also a regular contributor to ASCO Connection.
Dr. El Saghir is a recognized leader in cancer management and breast cancer expert in Lebanon and worldwide. He founded the Lebanese Society of Medical Oncology in 1997. He established monthly CME conferences and annual LSMO meetings since 1997. He chaired and is a regular speaker at Pan Arab Cancer Conferences Scientific Committees. He initiated and chaired annual post-ASCO meetings (ASCO Highlights in 1997 soon after the Annual ASCO meeting in Denver, Colorado that year; ASCO highlights meeting evolved into ASCO-sponsored Best of ASCO annual meetings of which he was one of the first to bring them to the International Scene to Tokyo, Mexico and Beirut since 2006).
Dr. El Saghir is author of “ABC of Breast Diseases” in Arabic and Awareness Booklet “Knowledge Road Map to Cure”. His professional and community services also include active involvement to ASCO, ESMO and BHGI efforts to reduce disparities in cancer management and outcome worldwide. He leads major breast cancer awareness campaigns and has appeared in over 500 TV and press interviews. His research, publications, media interventions, books, and community activities, along with his colleagues, are recognized to have led to significant down-staging of breast cancer in Lebanon and improved patients’ outcome for which has received the Medal of Honor for Achievements in 2002 and the National Cedar Medal of Honor - Rank Officer (2014) from the Presidents of Lebanon, Excellence in Cancer Research Prix 2015 du Centre National de Recherche Scientifique CNRS of Lebanon, awards from LSMO, Lebanese Order of Physicians, Cairo University, League of Womens’ Rights and many others. @NagiSaghir, www.facebook.com/ Nagi El Saghir , www.saghironline.com, www.aub.edu.lb
Stephen Johnston is Professor of Breast Cancer Medicine and Consultant Medical Oncologist at the Royal Marsden NHS Foundation Trust & Institute of Cancer Research, London. He was the first Director of the UK’s National Institute for Health Research (NIHR) Biomedical Research Centre for Cancer at the Royal Marsden. He graduated in 1983 from Trinity College at The University of Cambridge, and in 1986 from The Medical School at The University of Newcastle upon Tyne. He trained in General Medicine at St Bartholomew's Hospital and Hammersmith Hospital in London, and subsequently in Medical Oncology at the Royal Marsden Hospital. He gained his PhD from the Institute of Cancer Research at the University of London, and took up his current position as Medical Oncologist on the Breast Unit at the Royal Marsden Hospital in 1997. He has a specialist interest in the treatment of metastatic breast cancer, and his major research interests lie in understanding mechanisms of endocrine resistance in breast cancer. He is actively involved in facilitating the interface between basic and applied research, and is chief investigator of several phase II / III trials of novel therapeutic approaches in advanced disease, including new endocrine therapies and targeted signal transduction inhibitors. He has published over 230 breast cancer related articles in peer-reviewed journals, and is a regular invited lecturer at national & international meetings. He is a member of several scientific committees and advisory boards, a Faculty Member at the American Society for Clinical Oncology, the Deputy-Editor of the international journal ‘Breast Cancer Research’, and a former Trustee of the UK charity ‘Breast Cancer Campaign’ having also been Chairman of their Scientific Advisory Board.
Hamdy A. Azim is a Professor of Clinical Oncology at Cairo University in Egypt. He finished his doctorate degree on the management of non-Hodgkin's lymphoma in adults (1986). Dr Azim then obtained postdoctoral training at the Medical Oncology Department in NCI- Milan ( 1987) , the Medical Oncology Department in Curie Institute -Paris, France ( 1988-1989) , and at the Department of Adult Lymphoma and Bone Marrow Transplants, St. Louis Hospital in Paris( 1996) Dr Azim is a member of numerous societies including ASCO, ASH, ESMO , the European Blood and Marrow Transplantation Society (EBMT), and the American Society of Therapeutic Radiology (ASTRO). He sits on several international scientific / steering committees and has been invited as a speaker in more than 300 regional and international conferences. He also served as a speaker for the ASCO online educational programme. His main interests lie in breast cancer, molecular target therapies , bone metastases , Lymphoma and translation research where he has published more than 70 papers and 400 abstracts. Dr. Azim has been a principle investigator of many Multicenter international clinical trials mainly in breast cancer Dr Azim is an editor for the Journal of Clinical Lymphoma, The Lancet (Middle East edition), and the Journal of Clinical Oncology and Nuclear Medicine Cairo university. He was the chief editor of 2 educational books ( ASCO – PANARAB Lymphoma , 1999) and the MD Anderson Cancer Centre / Cairo University joint meeting (2006). Dr Azim serves as a referee for the Annals of Oncology Journal, THE BREAST , Chemotherapy Journal , Advances in Cancer Research and Journal of the Egyptian National Cancer Institute. He has been honoured with several awards including Scientist of the Year from the International Biographical Centre, Cambridge, UK (2002), the Order of Merit, Cambridge University (2002), the Best Arab Oncologist from the Lebanese Society of Medical Oncology (LSMO,2004) and the recognition award for significant contribution to the Oncology field in the middle east from UAE (Dubai -2013)
Dr Azim was the first to represent the Middle Eastern Region on the ASCO International Affairs Committee from 1997 to 2002. Together with international cancer research leaders, and the French president J. Chiraque, Dr Azim signed the “Charter of Paris against Cancer” on behalf of the Arab World in February 2000. On 2008, Dr. Azim was nominated as the chairman of the steering committee of the NCCN Middle East , which is responsible to set the guide lines of the management of certain cancers in the region. On January 2012 , Dr. Azim was elected to serve as the chairman of the department of clinical oncology ,faculty of medicine,Cairo University
Dorria Salem 1953, Egyptian radiologist, MD, Cairo University 1987. A professor at Cairo University teaching hospital, since 1998 and the general manager of the women's health outreach program [National Egyptian breast screening program] since 2007. She is one of the pioneers in the women's imaging the thing that put her in a very distinguished position on the national level as well as the Arab level. She is the founder of the women's imaging unit at the radiology department at Cairo university teaching hospital since 2003. She is also a member of the continuous teaching program of Cairo University and the ministry of health and population. She has recently been selected to be a member in the Middle East board of Aunt Minnie radiology website.
Dr Sudeep Gupta, completed his MBBS, MD and DM from All India Institute of Medical Sciences, New Delhi, in the year 2000 and has been a faculty member in the Department of Medical Oncology at Tata Memorial Centre since then. He has been a prolific clinical researcher who is actively involved in planning, organizing, conducting and analyzing Phase I, II and III clinical trials and has been a Principal Investigator or Co-investigator in more than 100 trials. He takes special interest in breast and gynecological cancers and early drug development. His research areas have involved implementation science including access to medications, guideline development, testing concepts and technology in clinical trials, innovative therapeutic strategies, toxicity and quality-of-life studies, pharmacokinetics and translational studies involving next-generation sequencing technology. He has published more than 120 papers in peer reviewed journals.
Since 2013 he has been the Deputy Director of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) one of the premier cancer translational research centres in India. He is currently engaged in facilitating cross talk between various stakeholders in cancer research at the institutional and national level, including basic scientists, clinical researchers, computational biologists, physicists, engineers and others.
Dr. Mounika Boppana, M.B.,B.S from Siddhartha Medical College, Dr.N.T.R. University of Health Sciences, Vijayawada, Andhra Pradesh (2004-2010) M.D , General Medicine from Kasturba Medical College, Manipal University, Manipal, Karnataka (2011 – 2014). She is currently Senior Registrar, Department of Medical Oncology, Tata Memorial Hospital, Mumbai since 2014.